What does CUSIP 921659108 represent in this 13F holders report?

CUSIP 921659108 is the security identifier for VNDA - Vanda Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VNDA - Vanda Pharmaceuticals Inc. - Common Stock in Q2 2015?

109 institutional investors reported VNDA - Vanda Pharmaceuticals Inc. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 59,119,327
Total 13F shares: 42,413,548
Share change: -3,953,431
Total reported value: $538,068,965
Put/Call ratio: 52%
Price per share: $12.69
Number of holders: 109
Value change: -$35,411,925
Number of buys: 61
Number of sells: 51

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 921659108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GOLDMAN SACHS GROUP INC	13F	Company	7.1%	4,205,392	$39,110,000	—	31 Mar 2015	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	7%	4,134,157	$38,448,000	—	31 Mar 2015	13F
PAULSON & CO. INC.	13F	Company	6.7%	3,950,000	$36,735,000	—	31 Mar 2015	13F
Palo Alto Investors LP	13F	Company	6.4%	3,803,408	$35,372,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	5%	2,955,429	$27,485,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	4.5%	2,685,595	$24,974,000	—	31 Mar 2015	13F
ARMISTICE CAPITAL, LLC	13F	Company	3.9%	2,284,000	$21,241,000	—	31 Mar 2015	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	3.3%	1,932,189	$17,969,000	—	31 Mar 2015	13F
BAKER BROS. ADVISORS LP	13F	Company	3%	1,750,230	$16,277,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.7%	1,599,162	$14,872,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	2.5%	1,485,191	$13,812,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	2.4%	1,421,114	$13,217,000	—	31 Mar 2015	13F
GREAT POINT PARTNERS LLC	13F	Company	2.3%	1,388,599	$12,914,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	2.1%	1,248,686	$11,612,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.9%	1,111,149	$10,334,000	—	31 Mar 2015	13F
Invesco Ltd.	13F	Company	1.7%	1,022,178	$9,506,000	—	31 Mar 2015	13F
Jefferies Group LLC	13F	Company	1.4%	830,402	$7,723,000	—	31 Mar 2015	13F
MACQUARIE GROUP LTD	13F	Company	1.2%	709,474	$6,598,000	—	31 Mar 2015	13F
J. Goldman & Co LP	13F	Company	0.99%	584,285	$5,434,000	—	31 Mar 2015	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.92%	543,390	$5,054,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.78%	462,602	$4,303,000	—	31 Mar 2015	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.67%	396,070	$3,683,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.65%	382,364	$3,554,000	—	31 Mar 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.62%	365,628	$3,400,000	—	31 Mar 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.6%	352,781	$3,281,000	—	31 Mar 2015	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.59%	350,000	$3,255,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.38%	224,072	$2,083,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.37%	220,731	$2,053,000	—	31 Mar 2015	13F
Alyeska Investment Group, L.P.	13F	Company	0.34%	202,216	$1,881,000	—	31 Mar 2015	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.34%	201,635	$1,875,000	—	31 Mar 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.33%	195,100	$1,814,000	—	31 Mar 2015	13F
ASCEND CAPITAL, LLC	13F	Company	0.28%	168,300	$1,566,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.28%	162,892	$1,515,000	—	31 Mar 2015	13F
BLUE ARROW CAPITAL MANAGEMENT LLC	13F	Company	0.27%	160,000	$1,488,000	—	31 Mar 2015	13F
TFS CAPITAL LLC	13F	Company	0.22%	132,314	$1,231,000	—	31 Mar 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.22%	128,249	$1,193,000	—	31 Mar 2015	13F
SABBY MANAGEMENT, LLC	13F	Company	0.19%	113,165	$1,052,000	—	31 Mar 2015	13F
QS Investors, LLC	13F	Company	0.19%	110,486	$1,027,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.18%	103,719	$965,000	—	31 Mar 2015	13F
CREDIT AGRICOLE S A	13F	Individual	0.17%	100,784	$937,000	—	31 Mar 2015	13F
SG Americas Securities, LLC	13F	Company	0.17%	99,604	$926,000	—	31 Mar 2015	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	73,700	$879,000	—	31 Mar 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.15%	89,640	$834,000	—	31 Mar 2015	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.15%	86,041	$800,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.14%	82,797	$771,000	—	31 Mar 2015	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.14%	80,383	$748,000	—	31 Mar 2015	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	79,300	$737,000	—	31 Mar 2015	13F
Trexquant Investment LP	13F	Company	0.13%	78,400	$729,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	74,553	$694,000	—	31 Mar 2015	13F
JW Asset Management, LLC	13F	Company	0.12%	70,080	$652,000	—	31 Mar 2015	13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2015

As of 30 Jun 2015, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,413,548 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, PAULSON & CO. INC., Palo Alto Investors, LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Fund Advisors, MORGAN STANLEY, venBio Select Advisor LLC, and GREAT POINT PARTNERS LLC. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

108

Q2 2015 holders

109

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.